ArticleJCO precision oncology2019

Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic Tumors.

Toby Trahair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.